Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the indoleacetic acid class. First synthesized in the 1960s, it has remained a potent therapeutic option for managing inflammatory conditions, acute gout, and certain neonatal disorders. Its clinical utility is balanced by a well-defined but significant side effect profile, necessitating careful patient selection and monitoring. This report provides a concise overview of indomethacin's pharmacology, therapeutic indications, adverse effects, and practical considerations for clinical use.

Pharmacology

Indomethacin exerts its anti-inflammatory, analgesic, and antipyretic effects primarily through inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes catalyze the conversion of arachidonic acid to prostaglandins, leukotrienes, and other mediators of inflammation. By blocking both isoforms, indomethacin reduces prostaglandin synthesis, thereby decreasing pain, fever, and swelling. However, COX-1 inhibition also disrupts the production of cytoprotective prostaglandins in the gastric mucosa and interferes with platelet aggregation and renal blood flow, accounting for many of its adverse effects.

Indomethacin is also a potent inhibitor of neutrophil migration and function, and it suppresses the release of inflammatory cytokines. In neonatal pharmacology, it has a unique mechanism for closing a patent ductus arteriosus (PDA) by inhibiting prostaglandin E2, which maintains ductal patency in utero. The drug is highly bound to plasma proteins (approximately 90%) and undergoes extensive hepatic metabolism via glucuronidation and oxidative pathways. Its elimination half-life ranges from 2.5 to 6 hours in adults but is prolonged in neonates and older patients.

Clinical Indications

Indomethacin is indicated for a variety of inflammatory and pain conditions. In rheumatology, it is used for moderate to severe rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, particularly when other NSAIDs are ineffective or not tolerated. It is also highly effective for acute gouty arthritis, often providing rapid relief within hours. Despite its efficacy, indomethacin is generally not considered a first-line therapy for chronic conditions due to its gastrointestinal and renal risks; alternative NSAIDs with better safety profiles are often preferred.

A unique and critical indication is the medical closure of a hemodynamically significant PDA in preterm infants. Indomethacin (usually intravenous) promotes ductal constriction, reducing left-to-right shunting and improving cardiorespiratory status. It has largely replaced surgical ligation in many neonatal intensive care units, although its use requires careful monitoring for transient renal impairment and decreased platelet function. Indomethacin is also used for the treatment of acute pericarditis, Bartter syndrome (to reduce hyperprostaglandinism), and to prevent preterm labor (though this is off-label and controversial due to fetal risks).

Dosage and Administration

For adults, oral indomethacin is dosed at 25–50 mg two to four times daily, with a maximum of 200 mg [laliqua.es] per day. To minimize gastrointestinal irritation, the immediate-release capsules should be taken with food or milk. Extended-release formulations are available for once or twice daily dosing. For acute gout, a loading dose of 50 mg followed by 25 mg three times daily for several days is typical. In neonates, intravenous indomethacin is given as a three-dose regimen (0.1–0.2 mg/kg per dose at 12–24 hour intervals), though dosing adjustments are needed for renal function and postnatal age.

Adverse Effects

The most common adverse effects are gastrointestinal: dyspepsia, nausea, abdominal pain, and diarrhea. More serious gastric ulcers, bleeding, and perforation can occur, especially in elderly or debilitated patients taking high doses or concomitant anticoagulants. The cardiovascular risk is increased with chronic use, including hypertension, edema, and heart failure exacerbation. Indomethacin also carries a risk of thromboembolic events, though less than with selective COX-2 inhibitors.

Renal adverse effects include decreased glomerular filtration rate, acute kidney injury, hyperkalemia, and fluid retention. In neonates, transient oliguria and elevated serum creatinine are common but usually reversible. Central nervous system effects are notable: headaches (sometimes severe), dizziness, confusion, and mood disturbances. Less common but serious effects include hepatotoxicity, blood dyscrasias (neutropenia, agranulocytosis), and hypersensitivity reactions.

Contraindications and Precautions

Indomethacin is contraindicated in patients with known hypersensitivity to any NSAID, in the setting of active peptic ulcer disease or gastrointestinal bleeding, and in severe renal or hepatic impairment. It should be avoided in pregnant women, especially during the third trimester, due to the risk of premature closure of the ductus arteriosus and oligohydramnios. Use in breastfeeding mothers is not recommended. Caution is warranted in patients with cardiovascular disease, hypertension, asthma (may exacerbate aspirin-sensitive asthma), and fluid retention.

Drug Interactions

Concomitant use with anticoagulants (e.g., warfarin) increases bleeding risk. Indomethacin may reduce the antihypertensive effects of beta-blockers, ACE inhibitors, and diuretics. Lithium and methotrexate levels may rise due to reduced renal clearance. Probiotic or antacid use may diminish absorption.

Conclusion

Indomethacin remains a valuable but potent NSAID with distinct roles in acute gout, certain rheumatic diseases, and neonatal PDA closure. Its broad spectrum of efficacy is tempered by significant gastrointestinal, renal, and cardiovascular risks. Clinicians must weigh these risks carefully, tailoring therapy to individual patients, and ensuring close monitoring for adverse events. Newer NSAIDs with improved safety profiles have reduced its use for chronic conditions, but its rapid onset and profound anti-inflammatory action ensure its continued relevance in specific clinical scenarios. A thorough understanding of its pharmacology, indications, and potential toxicities is essential for safe and effective prescribing.